Nili Schutz
Mapi Pharma (Israel)(IL)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Biochemical and Molecular Research, Cancer-related Molecular Pathways, Sphingolipid Metabolism and Signaling, ATP Synthase and ATPases Research
Most-Cited Works
- → Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening(2010)87 cited
- → 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase(2012)38 cited
- → Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS(2010)37 cited
- → Discovery of a Potent, S1P3-Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1)(2010)19 cited
- → Structural and Functional Insights into the Biofilm-Associated BceF Tyrosine Kinase Domain from Burkholderia cepacia(2021)3 cited
- → In vivo tumor growth inhibition by novel PKM2 cancer metabolism modulators.(2011)1 cited
- → Abstract 4065: Modulation of cancer metabolism with novel PKM2 activators exerts anti-tumor activity(2011)1 cited
- → Specific, High-Avidity Transient Receptor Potential Ion Channel Inhibitors Demonstrate an Approach to Keratoderma Therapy(2025)
- → Abstract 3219: Changing the metabolism of cancer cells with PKM2 activators - a path to a cancer metabolism drug(2012)